21555 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole Benzodiazepines
IMAGING METHOD FOR DESIGNER RECEPTOR, ANTAGONIST OR AGONIST, PHARMACEUTICAL, AND COMPANION DIAGNOSTIC AGENT
#2PET TRACERS FOR VISUALIZING GABAA GAMMA1 RECEPTORS
#3PET IMAGING TRACERS
#4CHOLECYSTOKININ B RECEPTOR TARGETING FOR IMAGING AND THERAPY
#5NOVEL COMPOUND BINDING TO DESIGNER RECEPTOR, IMAGING METHOD FOR DESIGNER RECEPTOR, AGONIST OR ANTAGONIST, THERAPEUTIC AGENT, COMPANION DIAGNOSTIC AGENT, AND IMAGING METHOD FOR NERVE CELL
#6Cholecystokinin B receptor targeting for imaging and therapy
#7Radiolabeled and fluorescent PARP inhibitors for imaging and radiotherapy
#8Cholecystokinin B receptor targeting for imaging and therapy
#9Cholecystokinin B receptor targeting for imaging and therapy
#10Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof
#11Synthesis of 18F-labeled tracers in hydrous organic solvents
#12[18F] LABELLED ANALOGUES OF FLUMAZENIL AS IN VIVO IMAGING AGENTS
#13Gentisic acid for stabilising 123-I radiopharmaceuticals
#14PIPERAZINYL AND DIAZAPANYL BENZAMIDES AND BENZTHIOAMIDES